APA (7th ed.) Citation

Chen, C., & Liu, Y. (2021). MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland), 14(2), 130. https://doi.org/10.3390/ph14020130

Chicago Style (17th ed.) Citation

Chen, Chao-Ju, and Yu-Peng Liu. "MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer." Pharmaceuticals (Basel, Switzerland) 14, no. 2 (2021): 130. https://doi.org/10.3390/ph14020130.

MLA (9th ed.) Citation

Chen, Chao-Ju, and Yu-Peng Liu. "MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer." Pharmaceuticals (Basel, Switzerland), vol. 14, no. 2, 2021, p. 130, https://doi.org/10.3390/ph14020130.